应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
GCVRZ Sanofi
停牌 03-03 16:00:00 EST
0.8711
+0.0000
0.00%
最高
0.8711
最低
0.8711
成交量
0.00
今开
0.8711
昨收
0.8711
日振幅
0.00%
总市值
10.92亿
流通市值
9.71亿
总股本
12.54亿
成交额
0.00
换手率
0.00%
流通股本
11.15亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
阿尔戈斯咨询公司：维持Sanofi(SNY.US)评级，由买入调整至买入评级, 目标价由55.00美元调整至60.00美元。
智通财经 · 07-27
阿尔戈斯咨询公司：维持Sanofi(SNY.US)评级，由买入调整至买入评级, 目标价由55.00美元调整至60.00美元。
Sanofi(SNY.US)：2024年Q2财报实现营收115.68亿美元，前值为108.6亿美元，预期值为113.1亿美元；
智通财经 · 07-25
Sanofi(SNY.US)：2024年Q2财报实现营收115.68亿美元，前值为108.6亿美元，预期值为113.1亿美元；
【再生元(REGN.US)/赛诺菲(SNY.US)Dupixent在欧盟获批用于治疗慢性阻塞性肺病成人患者】智通财经APP获悉，7月3日，欧洲药品管理局(EMA)批准了再生元(Regeneron Pharmaceuticals)与赛诺菲(Sanofi)的重磅疗法Dupixent(dupilumab)作为一种附加维持治疗药物，用于治疗以血液嗜酸性粒细胞升高为特征、且未得到控制的慢性阻塞性肺病(COPD)成人患者。
智通财经 · 07-04
【再生元(REGN.US)/赛诺菲(SNY.US)Dupixent在欧盟获批用于治疗慢性阻塞性肺病成人患者】智通财经APP获悉，7月3日，欧洲药品管理局(EMA)批准了再生元(Regeneron Pharmaceuticals)与赛诺菲(Sanofi)的重磅疗法Dupixent(dupilumab)作为一种附加维持治疗药物，用于治疗以血液嗜酸性粒细胞升高为特征、且未得到控制的慢性阻塞性肺病(COPD)成人患者。
赛诺菲有意出售旗下消费者保健部门 要求竞购者7月中旬前提出第一轮报价据知情人士透露，法国制药巨头赛诺菲(Sanofi SA)已对其价值200亿美元的消费者保健部门发起了初步竞购。
格隆汇 · 06-26
赛诺菲有意出售旗下消费者保健部门 要求竞购者7月中旬前提出第一轮报价据知情人士透露，法国制药巨头赛诺菲(Sanofi SA)已对其价值200亿美元的消费者保健部门发起了初步竞购。
【赛诺菲有意出售旗下消费者保健部门 要求竞购者7月中旬前提出第一轮报价】据知情人士透露，法国制药巨头赛诺菲(Sanofi SA)已对其价值200亿美元的消费者保健部门发起了初步竞购。
东方财富网 · 06-26
【赛诺菲有意出售旗下消费者保健部门 要求竞购者7月中旬前提出第一轮报价】据知情人士透露，法国制药巨头赛诺菲(Sanofi SA)已对其价值200亿美元的消费者保健部门发起了初步竞购。
【预防婴幼儿RSV感染 赛诺菲(SNY.US)鼻喷疫苗在中国获批临床】智通财经APP获悉，赛诺菲(Sanofi/SNY.US)近日宣布，其婴幼儿鼻喷呼吸道合胞病毒减毒活疫苗(简称“RSVt疫苗”，SP0125)已经获得中国国家药监局药品审评中心(CDE)批准开展临床研究。
智通财经 · 06-05
【预防婴幼儿RSV感染 赛诺菲(SNY.US)鼻喷疫苗在中国获批临床】智通财经APP获悉，赛诺菲(Sanofi/SNY.US)近日宣布，其婴幼儿鼻喷呼吸道合胞病毒减毒活疫苗(简称“RSVt疫苗”，SP0125)已经获得中国国家药监局药品审评中心(CDE)批准开展临床研究。
加载更多
公司概况
公司名称：
Sanofi
所属市场：
NASDAQ
上市日期：
--
主营业务：
Sanofi-Aventis is a global pharmaceutical group engaged in the research, development, manufacture and marketing of healthcare products. Co.'s business includes two main activities: pharmaceuticals and human vaccines (Vaccines).
发行价格：
--
{"stockData":{"symbol":"GCVRZ","market":"US","secType":"STK","nameCN":"Sanofi","latestPrice":0.8711,"timestamp":1583269200000,"preClose":0.8711,"halted":3,"volume":0,"delay":0,"floatShares":1114622547,"shares":1254041488,"eps":2.519335,"marketStatus":"停牌","marketStatusCode":5,"change":0,"latestTime":"03-03 16:00:00 EST","open":0.8711,"high":0.8711,"low":0.8711,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.519335,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732006800000},"adr":0,"adjPreClose":0.8711,"adrRate":0,"dividendRate":4.027632,"volumeRatio":0},"requestUrl":"/m/hq/s/GCVRZ","defaultTab":"news","newsList":[{"id":"2454372650","title":"阿尔戈斯咨询公司：维持Sanofi(SNY.US)评级，由买入调整至买入评级, 目标价由55.00美元调整至60.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2454372650","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454372650?lang=zh_cn&edition=full","pubTime":"2024-07-27 03:24","pubTimestamp":1722021852,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["SNY","BK4585","BK4588","GCVRZ","IE00BFXG1179.USD","SNYNF","BK4007"],"gpt_icon":0},{"id":"2454177548","title":"Sanofi(SNY.US)：2024年Q2财报实现营收115.68亿美元，前值为108.6亿美元，预期值为113.1亿美元；","url":"https://stock-news.laohu8.com/highlight/detail?id=2454177548","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454177548?lang=zh_cn&edition=full","pubTime":"2024-07-25 15:21","pubTimestamp":1721892109,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["GCVRZ","BK4585","BK4007","SNY","SNYNF","BK4588","IE00BFXG1179.USD"],"gpt_icon":0},{"id":"2448454200","title":"【再生元(REGN.US)/赛诺菲(SNY.US)Dupixent在欧盟获批用于治疗慢性阻塞性肺病成人患者】智通财经APP获悉，7月3日，欧洲药品管理局(EMA)批准了再生元(Regeneron Pharmaceuticals)与赛诺菲(Sanofi)的重磅疗法Dupixent(dupilumab)作为一种附加维持治疗药物，用于治疗以血液嗜酸性粒细胞升高为特征、且未得到控制的慢性阻塞性肺病(COPD)成人患者。","url":"https://stock-news.laohu8.com/highlight/detail?id=2448454200","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448454200?lang=zh_cn&edition=full","pubTime":"2024-07-04 08:00","pubTimestamp":1720051242,"startTime":"0","endTime":"0","summary":null,"market":"uk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0058720904.USD","LU2023250504.SGD","LU2362540622.SGD","SNY","BK7124","BK4139","LU0889565916.HKD","LU2362541513.USD","LU0289739699.SGD","LU0320765992.SGD","BK4585","GCVRZ","LU1917777945.USD","BK5011","LU2106854487.HKD","REGN","LU0053666078.USD","0O59.UK","BK4007","LU0114720955.EUR","SNYNF","LU2362541273.HKD","LU0882574055.USD","LU0109394709.USD","ICS.AU","LU1974910355.USD","BK4588"],"gpt_icon":0},{"id":"2446870121","title":"赛诺菲有意出售旗下消费者保健部门 要求竞购者7月中旬前提出第一轮报价据知情人士透露，法国制药巨头赛诺菲(Sanofi SA)已对其价值200亿美元的消费者保健部门发起了初步竞购。","url":"https://stock-news.laohu8.com/highlight/detail?id=2446870121","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446870121?lang=zh_cn&edition=full","pubTime":"2024-06-26 06:32","pubTimestamp":1719354778,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IE00BLSP4452.SGD","SNYNF","0O59.UK","PAI","TPG","BK4007","BK1574","BK4135","01477","GCVRZ","BX","BK5011","IE0004445239.USD","BK1191","BK4588","IE00BLSP4239.USD","BK4585","IE00BBT3K403.USD"],"gpt_icon":0},{"id":"2446682462","title":"【赛诺菲有意出售旗下消费者保健部门 要求竞购者7月中旬前提出第一轮报价】据知情人士透露，法国制药巨头赛诺菲(Sanofi SA)已对其价值200亿美元的消费者保健部门发起了初步竞购。","url":"https://stock-news.laohu8.com/highlight/detail?id=2446682462","media":"东方财富网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446682462?lang=zh_cn&edition=full","pubTime":"2024-06-26 01:05","pubTimestamp":1719335119,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wap.eastmoney.com/a/202406263113434050.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_eastmoney","symbols":["BK4007","BK4135","BK1191","BK4585","IE00BLSP4239.USD","TPG","IE0004445239.USD","BK4588","01477","PAI","BX","BK5011","IE00BLSP4452.SGD","SNYNF","GCVRZ","BK1574","IE00BBT3K403.USD","0O59.UK"],"gpt_icon":0},{"id":"2441623290","title":"【预防婴幼儿RSV感染 赛诺菲(SNY.US)鼻喷疫苗在中国获批临床】智通财经APP获悉，赛诺菲(Sanofi/SNY.US)近日宣布，其婴幼儿鼻喷呼吸道合胞病毒减毒活疫苗(简称“RSVt疫苗”，SP0125)已经获得中国国家药监局药品审评中心(CDE)批准开展临床研究。","url":"https://stock-news.laohu8.com/highlight/detail?id=2441623290","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2441623290?lang=zh_cn&edition=full","pubTime":"2024-06-05 11:12","pubTimestamp":1717557148,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK5011","159646","GCVRZ","BK4588","SNY","SNYNF","BK4007","BK4585","CDE","0O59.UK","BK4017"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sanofi.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0208},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0567},{"period":"6month","weight":0.1063},{"period":"1year","weight":0.301},{"period":"ytd","weight":0.2324}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Sanofi-Aventis is a global pharmaceutical group engaged in the research, development, manufacture and marketing of healthcare products. Co.'s business includes two main activities: pharmaceuticals and human vaccines (Vaccines).","exchange":"NASDAQ","name":"Sanofi","nameEN":"Sanofi SA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Sanofi(GCVRZ)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Sanofi(GCVRZ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Sanofi,GCVRZ,Sanofi股票,Sanofi股票老虎,Sanofi股票老虎国际,Sanofi行情,Sanofi股票行情,Sanofi股价,Sanofi股市,Sanofi股票价格,Sanofi股票交易,Sanofi股票购买,Sanofi股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Sanofi(GCVRZ)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Sanofi(GCVRZ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}